Obviousness-By-Inherency Argument Nixed By Sarah A. Kagan The U.S. Court of Appeals for the Federal Circuit affirmed on July 13 a Delaware district court’s decision that patent challenger Custopharm
Banner & Witcoff was recognized by Law360 for its role in client Comcast’s dispute with TiVo over patented technology related to television program guides, digital video recorders and mobile services. Click here to read the
Katie Laatsch Fink and Rebecca Rokos are featured in Crain’s 2018 Notable Women Lawyers in Chicago. The special section of the publication celebrates senior-level women in law within the Chicagoland
On July 11, our Washington, D.C. office put together 300 sandwiches for Martha’s Table to use on McKenna’s Wagon, its mobile food truck that provides its downtown neighbors with a healthy meal 365
Robert H. Resis, chair of the Intellectual Property Law Association of Chicago (IPLAC) Amicus Committee, has joined other intellectual property lawyers in representing the IPLAC as amicus curiae in a
Patent Wars: Genome Editing By Sarah A. Kagan The hotly contested patent rights to CRISPR-Cas9 “genome editing” technology are still unsettled, as two groups of inventors await a decision
BIO’s China Summit Highlights Trends in BioPharma Market By Pei Wu In June, the Biotechnology Innovation Organization celebrated its 25th anniversary in Boston. The BIO International Convention drew more
Full Measure of Compensation for Infringement By Sarah A. Kagan Yet again the Supreme Court struck down a rigid Court of Appeals for the Federal Circuit rule in favor
On June 28, 2018, the Patent Trial and Appeal Board denied two Skechers’ inter partes review challenges directed at design patents covering NIKE’s popular FREE outsole designs. After defeating Skechers’
Should “Blocking Patents” be Used as a Blunt Weapon or as a Factor in a Sophisticated Economic Analysis? By Sarah A. Kagan In recent oral arguments in a dispute
